|
Pretreatment With P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction
|
|
0
|
2
|
November 5, 2025
|
|
B004 Hypertension Combination Medication Plan
|
|
0
|
10
|
July 20, 2025
|
|
Overview of Antihypertensive Drugs
|
|
0
|
6
|
July 20, 2025
|
|
20250625 Training Course Notes (Guo Weiqin Clinical Experience Overview of Cardiovascular Diseases)
|
|
0
|
8
|
June 25, 2025
|
|
Cardiac Injury and Myocardial Infarction Test Indicators (Myocardial Enzyme Spectrum)
|
|
0
|
7
|
May 26, 2025
|
|
Creatine Kinase and Isoenzymes CK Study Notes in Plain Language
|
|
0
|
3
|
May 26, 2025
|
|
Course on Myocardial Injury Related Indicators—BNP, Myocardial Enzyme Profile, Troponin
|
|
3
|
15
|
May 26, 2025
|
|
Learning Notes on Troponin cTnI and cTnT Explained Simply
|
|
0
|
8
|
May 26, 2025
|
|
Why is it important to specifically distinguish whether a myocardial infarction has ST-segment elevation? Leading to two main categories: STEMI and NSTE-ACS
|
|
0
|
5
|
May 26, 2025
|
|
Natriuretic Peptides and Heart Failure
|
|
0
|
12
|
January 29, 2024
|
|
BNP Natriuretic Peptide Study Notes in Plain Language
|
|
0
|
7
|
May 15, 2025
|
|
Acute left heart failure causing pulmonary hemorrhage with pink frothy sputum real video
|
|
0
|
15
|
October 10, 2024
|
|
Large-scale clinical trials CHANCE and CHANCE-2 led by China rewrite international treatment guidelines
|
|
0
|
74
|
May 10, 2024
|
|
Clopidogrel, Ticagrelor and CYP2C19, CYP3A4 Pharmacology and Metabolism
|
|
1
|
134
|
May 10, 2024
|
|
Antiplatelet Drugs (From Physiology to Internal Medicine)
|
|
0
|
247
|
January 3, 2024
|
|
Chinese Expert Consensus on Perioperative Cardiovascular Disease Management in Non-Cardiac Surgery
|
|
0
|
171
|
February 23, 2024
|
|
Same cause, different results
|
|
1
|
168
|
February 18, 2024
|
|
Cardiology Series Teaching Videos – ICU Doctor’s Advancement
|
|
0
|
205
|
February 6, 2024
|
|
National Heart Failure Guidelines 2023 (Simplified Version)
|
|
1
|
101
|
January 30, 2024
|
|
[Consensus] Interpretation of the General Definition and Classification of Heart Failure
|
|
0
|
149
|
January 29, 2024
|
|
Classification and Staging of Heart Failure (2023 Heart Failure Guidelines)
|
|
0
|
126
|
January 27, 2024
|
|
Coagulation mechanism and the principle of warfarin action
|
|
0
|
129
|
January 22, 2024
|
|
(Draft) Bradycardia
|
|
0
|
134
|
January 22, 2024
|
|
Learning Process of Coagulation/Anticoagulation/Fibrinolysis Related Knowledge
|
|
6
|
567
|
January 21, 2024
|
|
A Case of Myocardial Infarction Misdiagnosed as Cholecystitis and How to Reduce Missed Diagnosis Rate of Myocardial Infarction
|
|
1
|
245
|
January 21, 2024
|
|
Cardiac vagal reflex
|
|
0
|
173
|
January 17, 2024
|
|
Cardioneuro Syndrome
|
|
0
|
204
|
January 17, 2024
|
|
Differences between Atorvastatin and Rosuvastatin
|
|
1
|
199
|
January 17, 2024
|
|
Baishui's ECG Learning Experience
|
|
0
|
138
|
January 16, 2024
|
|
Overview of Coronary Atherosclerosis, Coronary Heart Disease, Stable Angina, Unstable Angina, and Acute Coronary Syndrome
|
|
0
|
125
|
January 5, 2024
|